News & Events
ChemGenex Announces Poster Presentations at the 49th Annual Meeting of the American Society of Hematology
17 / 12 / 2007
ChemGenex Investigators Report Omacetaxine Effective in Killing CML Stem Cells in Animal Model Studies
11 / 12 / 2007
ChemGenex Investigators Report Activity of Omacetaxine in Imatinib-Resistant Chronic Myeloid Leukemia Patients with the T315I Mutation
10 / 12 / 2007
Cryptopharma raises $0.8m to progress cystic fibrosis drug Cryptopharma appoints David Crump as new CEO
17 / 10 / 2007
ChemGenex Announces Positive Preliminary Data from Phase 2/3 Clinical Trial of Ceflatoninr at International Conference
10 / 10 / 2007
ChemGenex Appoints Experienced Biotechnology Executive as Chief Medical Officer Chief Medical Officer
08 / 10 / 2007
ChemGenex Announces Second Publication Demonstrating Activity of Ceflatoninr in T315I-Positive Chronic Myeloid Leukemia (CML)
24 / 09 / 2007
C-PulseTM Pilot Clinical Trial Results Presented FDA Meeting Scheduled for US Clinical Trial
14 / 08 / 2007
Displaying records 551-575 of 705